Aclaris Therapeutics (ACRS) Preferred Dividend Payments (2014 - 2015)
Aclaris Therapeutics (ACRS) recorded quarterly Preferred Dividend Payments of $213000.0 in Q4 2015, down 79.12% quarter-over-quarter from $1.0 million in Q3 2015, and down 67.73% on a YoY basis from $660000.0 in Q4 2014.
Aclaris Therapeutics (ACRS) Preferred Dividend Payments (2014 - 2015) Analysis & Trends
Aclaris Therapeutics' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $213000.0 for Q4 2015.
- In Q4 2015, Preferred Dividend Payments fell 67.73% year-over-year to $213000.0; the TTM figure through Dec 2015 stood at $2.6 million (changed N/A YoY), while the FY2015 annual figure was $2.6 million, up 24.93% from the prior year.
- Preferred Dividend Payments was $213000.0 for Q4 2015 at Aclaris Therapeutics, down from $1.0 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $1.0 million in Q3 2015 to a low of $213000.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Aclaris Therapeutics | 580.93 Mn | 580.93 Mn | 1.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 213,000.00 |
| Sep 30, 2015 | 1.02 Mn |
| Jun 30, 2015 | 676,000.00 |
| Mar 31, 2015 | 657,000.00 |
| Dec 31, 2014 | 660,000.00 |
| Sep 30, 2014 | 479,000.00 |